Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-6517

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-6517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906517)

The image shows a label for Venlafaxine Hydrochloride Extended-Release capsules, 75 mg strength, manufactured by A-S Medication Solutions. The label includes the product NDC 50090-6517-0 and indicates a package content of 90 capsules. Storage instructions recommend keeping the product at 68 to 77 degrees Fahrenheit.*

FDA Label Image

Figure (Venlafaxine Fig1)

A scatter plot chart illustrating fold change and 90% confidence intervals for pharmacokinetic parameters of venlafaxine in special populations. The chart compares Cmax and AUC values for venlafaxine, its ODV metabolite, and combined ODV metrics across hepatic and renal impairment, CYP2D6 polymorphism, age over 60 years, and gender differences, plotted relative to a reference value of 1.0.*

FDA Label Image

Figure (Venlafaxine Fig2)

A scatter plot chart showing fold change and 90% confidence intervals for venlafaxine pharmacokinetic parameters (Cmax, AUC) in the presence of various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole (CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium. The X-axis represents the change relative to the reference value, with data points distributed along the axis indicating increases or decreases in venlafaxine exposure.*

FDA Label Image

Figure (Venlafaxine Fig3)

A scatter plot chart showing the fold change and 90% confidence intervals in pharmacokinetic (PK) parameters (Cmax and AUC) of Venlafaxine Hydrochloride when co-administered with various interacting drugs including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The chart compares change relative to a reference value.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride showing the molecular framework with a cyclohexanol group, a methoxy-substituted aromatic ring, and a dimethylaminoethyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.